Woodline Partners LP Bio N Tech Se Transaction History
Woodline Partners LP
- $9.97 Billion
- Q2 2024
A detailed history of Woodline Partners LP transactions in Bio N Tech Se stock. As of the latest transaction made, Woodline Partners LP holds 112,538 shares of BNTX stock, worth $13.2 Million. This represents 0.09% of its overall portfolio holdings.
Number of Shares
112,538
Previous 54,735
105.61%
Holding current value
$13.2 Million
Previous $5.05 Million
79.1%
% of portfolio
0.09%
Previous 0.05%
Shares
4 transactions
Others Institutions Holding BNTX
# of Institutions
328Shares Held
40.6MCall Options Held
845KPut Options Held
1.23M-
Baillie Gifford & CO8.28MShares$974 Million0.53% of portfolio
-
Primecap Management CO Pasadena, CA4.79MShares$563 Million0.28% of portfolio
-
Flossbach Von Storch Ag Cologne, 2M4.38MShares$515 Million1.49% of portfolio
-
Harding Loevner LP Bridgewater, NJ2.93MShares$344 Million1.34% of portfolio
-
Black Rock Inc. New York, NY1.9MShares$223 Million0.0% of portfolio
About BioNTech SE
- Ticker BNTX
- Exchange NASDAQ
- Sector Healthcare
- Industry Biotechnology
- Shares Outstandng 242,684,992
- Market Cap $28.5B
- Description
- BioNTech SE, a biotechnology company, develops and commercializes immunotherapies for cancer and other infectious diseases. The company is developing FixVac product candidates, including BNT111, which is in Phase II clinical trial for advance melanoma; BNT112 that is in Phase I/IIa clinical trial for prostate cancer; BNT113, which is in Phase II...